Abstract
Background: Co-infection with the Hepatitis C virus (HCV) in HIVpositive patients is an emerging health problem. The factors affecting response to HCV-specific therapy are poorly understood but may involve host genetic factors. HCV NS5A-induced inhibition of TGF-b signaling has been suggested as a potential mechanism involved in HCV pathogenesis. TGF-b, a multifunctional cytokine, displays gene polymorphisms (TGF-b codon 10 T/C and codon 25G/C) associated with differential cytokine secretion. Here, we studied whether TGF-b gene polymorphisms affect the treatment response in HCV/HIV co-infection.
Original language | English |
---|---|
Pages (from-to) | S305-S306 |
Number of pages | 1 |
Journal | Journal of Hepatology |
Volume | 48 |
Publication status | Published - 2008 |
Keywords
- cytokines
- genetic polymorphisms
- hepatitis C virus